Key Quantitative Figures
The company reported that no shares were dematerialized during the month of October 2026.
The total number of dematerialized shares as of October 31, 2026, was 6,11,09,526.
This total is broken down as follows:
- NSDL: 5,25,35,270 shares
- CDSL: 85,74,256 shares
Comparative Figures
The data shows there was zero net change in the total number of dematerialized shares from the previous month. The total of 6,11,09,526 shares remained identical to the figure from September 30, 2026.
Parties Involved
The disclosure was signed by Ankit Jain, General Manager – Legal & Company Secretary for Panacea Biotec Limited.
The company's Registrar and Transfer Agent (RTA) is Skyline Financial Services Pvt. Ltd. (SEBI Registered Category-1 RTA, CIN: U74899DL1995PTC071324).
A certificate from the RTA confirming the dematerialized share count as of October 31, 2026, was enclosed with the filing as Annexure - 1.
Financial Impact
No financial impact is quantified in this operational compliance disclosure.